Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge

We report a patient with advanced bladder cancer in which the primary lesion and metastatic site disappeared following the pembrolizumab therapy rechallenge after radiotherapy for bladder cancer lesion of nonresponse of pembrolizumab first challenge. A 76-year-old man with advanced bladder cancer re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Taro, Hasegawa, Go, Kawaguchi, Gen, Ikeda, Yohei, Hara, Noboru, Nishiyama, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337140/
https://www.ncbi.nlm.nih.gov/pubmed/34367712
http://dx.doi.org/10.1155/2021/9087529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337140/
https://www.ncbi.nlm.nih.gov/pubmed/34367712
http://dx.doi.org/10.1155/2021/9087529

Ejemplares similares